<DOC>
	<DOC>NCT01488591</DOC>
	<brief_summary>The aim of this study : 1. Through the study of genes of protein, transporter, translator and epigenome investigating the effect of anti-cancer treatment or the key factor of the MDR (Multidrug resistance) on the blood cancer patients who are under the anti-cancer sork treatment 2. Giving a service of anticancer medicine therapeutic drug monitoring (TDM) and genotyping</brief_summary>
	<brief_title>Biomarker Research for Personalized Medicine</brief_title>
	<detailed_description />
	<mesh_term>Hematologic Neoplasms</mesh_term>
	<criteria>Korean Clinical diagnosis of Hematologic neoplasms</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
</DOC>